Chemomab Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Chemomab Therapeutics Ltd. (CMMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.76 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-23
- Chemomab Therapeutics Ltd. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 2.39M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|
| 2025-12-31 | 4.76M shares 20-F · filed 2026-03-23 | |
| 2025-06-30 | 4.76M shares 6-K · filed 2025-08-14 | |
| 2024-12-31 | 2.85M shares 20-F · filed 2026-03-23 | |
| 2023-12-31 | 15.06M shares 20-F · filed 2026-03-23 | |
| 2022-12-31 | 11.40M shares 20-F · filed 2025-04-04 | |
| 2021-12-31 | 17.78M shares 20-F · filed 2024-03-28 | |
| 2020-12-31 | 2.39M shares 10-K · filed 2022-03-30 |